Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
First Subject Enrolled in Phase 1 Study of MRX-5
2023-11-20 18:34
Sanyou's "STAL Platform" is a significant advancement in the field of drug discovery.
2023-11-18 08:00
CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update
2023-11-17 22:21
Taiwan Lubricate for academic research and health products development
2023-11-17 20:00
epitoMAP Inc., Animal Allergy Clinical Laboratories Inc. and Nippon Zenyaku Kogyo Co., Ltd. Enter into License Agreement
2023-11-17 16:00
WuXi XDC Successfully Listed on the Main Board of Hong Kong Stock Exchange
2023-11-17 14:00
Antengene Presents Encouraging Clinical Data from Four Pipeline Programs at the 2023 R&D Day
2023-11-17 08:00
Once-Weekly TransCon™ CNP Achieved Primary Efficacy Objective in ACcomplisH China Phase 2 Trial
2023-11-16 22:00
TB Alliance Launches Five-Country Phase 2 Clinical Trial Evaluating Next-Generation TB Drug
2023-11-16 20:20
ACROBiosystems launches GMP-grade DLL4 Protein to accelerate stem cell manufacturing
2023-11-16 20:08
Henlius Reported Financial Results for the First Three Quarters of 2023: Total Revenue Exceeded RMB3.9 billion, Profitability Further Improved
2023-11-15 20:16
RemeGen to Present Telitacicept Phase III Clinical Trial Results for Rheumatoid Arthritis Patients in a Late-Breaking Abstract Oral Presentation Session at the American College of Rheumatology
2023-11-15 16:35
"Read Medicine Labels" - How to Safely Use Green Chiretta Against COVID-19
2023-11-15 14:58
Riding the tide, realize the future: The BD paths for Chinese Biotech
2023-11-15 10:42
Noble Capital Markets Initiates Coverage on YS Biopharma With Outperform Rating and US$5.25 Price Target
2023-11-14 21:30
CytoMed Therapeutics to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference
2023-11-14 20:47
HaemaLogiX Announces Appointment of Damian Clarke-Bruce as Managing Director and CEO
2023-11-14 08:27
Brii Bio Presents New Data Highlighting Progress Towards Achieving HBV Functional Cure at AASLD's The Liver Meeting® 2023
2023-11-14 06:40
Brii Bio Presents New Data Highlighting Progress Towards Achieving HBV Functional Cure at AASLD's The Liver Meeting® 2023
2023-11-14 06:40
Telix Announces Proposed Acquisition of QSAM Biosciences and Its Lead Therapy Candidate, CycloSam®
2023-11-14 06:33
1
28
29
30
31
32
375